The purpose of this article is to systematically review the use of fentanyl as an analgesic for
breakthrough pain. This article found that the oral transmucosal fentanyl (OTFC) had a …

Objectives The kinetics of drug absorption for nasally administered drugs are often studied
using excised mucosal tissue. To avoid the disadvantages of animal experiments, cellular in …

In recent years, there has been a significant increase in the registration of drugs for nasal
application with systemic effects. Previous preclinical in vitro test systems for transmucosal …

Introduction An unsafe injection practice is one of the major contributors to new hepatitis C
virus (HCV) infections; thus, people who inject drugs are a key population to prioritize to …

Opioids are pivotal therapeutics in the management of escalated chronic pain (moderate–
severe). In the last two decades, the increased prescription rate and the prolonged usage of …

Due to its non‐invasive mode of administration, intranasal (IN) application of drugs may be a
valuable alternative to non‐invasive pain management. With characteristics that appear to …

Fentanyl, a short-acting synthetic pure opiate, offers an excellent option for the treatment of
cancer and chronic pain. While oral administration is not an option, its high potency and …

Breakthrough cancer pain (BTcP) is a common condition in oncological patients. However,
its management is still suboptimal. Improved knowledge of BTcP and its management in …

Objective: Intranasal fentanyl's (INF) effectiveness is established using highly concentrated
INF (HINF). Standard concentration INF (SINF) is more widely available. We aimed to …

Background Analgesia administration for children with vaso‐occlusive crises is often
delayed in the emergency department. Intranasal fentanyl (INF) has been shown to be safe …